ORKA
Oruka Therapeutics, Inc.
Stock
$84.52+1.10 (+1.32%)Close Oct 2, 2026
- Research and development, 2025
- $101M
- 5-year CAGR
- +82.3%
- 10-year CAGR
- +30.4%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $101M | — |
| 2023 | $1.0M | −78.7% |
| 2022 | $4.7M | −65.7% |
| 2021 | $14M | +177.1% |
| 2020 | $5.0M | +172.3% |
| 2019 | $1.8M | −56.8% |
| 2018 | $4.2M | −69.9% |
| 2017 | $14M | +14.0% |
| 2016 | $12M | +74.8% |
| 2015 | $7.1M | +25.6% |
| 2014 | $5.6M | +92.1% |
| 2013 | $2.9M | +168.1% |
| 2012 | $1.1M | −52.8% |
| 2011 | $2.3M | −25.5% |
| 2010 | $3.1M | — |